_version_ 1783685438374936576
author Teyssou, Elisa
Soulie, Cathia
Visseaux, Benoit
Lambert-Niclot, Sidonie
Ferre, Valentine
Marot, Stéphane
Jary, Aude
Sayon, Sophie
Zafilaza, Karen
Leducq, Valentin
Schnuriger, Aurélie
Abdi, Basma
Wirden, Marc
Houhou-Fidouh, Nadhira
Charpentier, Charlotte
Morand-Joubert, Laurence
Burrel, Sonia
Descamps, Diane
Calvez, Vincent
Marcelin, Anne Geneviève
author_facet Teyssou, Elisa
Soulie, Cathia
Visseaux, Benoit
Lambert-Niclot, Sidonie
Ferre, Valentine
Marot, Stéphane
Jary, Aude
Sayon, Sophie
Zafilaza, Karen
Leducq, Valentin
Schnuriger, Aurélie
Abdi, Basma
Wirden, Marc
Houhou-Fidouh, Nadhira
Charpentier, Charlotte
Morand-Joubert, Laurence
Burrel, Sonia
Descamps, Diane
Calvez, Vincent
Marcelin, Anne Geneviève
author_sort Teyssou, Elisa
collection PubMed
description
format Online
Article
Text
id pubmed-8080495
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The British Infection Association. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80804952021-04-29 The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients Teyssou, Elisa Soulie, Cathia Visseaux, Benoit Lambert-Niclot, Sidonie Ferre, Valentine Marot, Stéphane Jary, Aude Sayon, Sophie Zafilaza, Karen Leducq, Valentin Schnuriger, Aurélie Abdi, Basma Wirden, Marc Houhou-Fidouh, Nadhira Charpentier, Charlotte Morand-Joubert, Laurence Burrel, Sonia Descamps, Diane Calvez, Vincent Marcelin, Anne Geneviève J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2021-07 2021-04-28 /pmc/articles/PMC8080495/ /pubmed/33932451 http://dx.doi.org/10.1016/j.jinf.2021.04.023 Text en © 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Teyssou, Elisa
Soulie, Cathia
Visseaux, Benoit
Lambert-Niclot, Sidonie
Ferre, Valentine
Marot, Stéphane
Jary, Aude
Sayon, Sophie
Zafilaza, Karen
Leducq, Valentin
Schnuriger, Aurélie
Abdi, Basma
Wirden, Marc
Houhou-Fidouh, Nadhira
Charpentier, Charlotte
Morand-Joubert, Laurence
Burrel, Sonia
Descamps, Diane
Calvez, Vincent
Marcelin, Anne Geneviève
The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
title The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
title_full The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
title_fullStr The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
title_full_unstemmed The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
title_short The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
title_sort 501y.v2 sars-cov-2 variant has an intermediate viral load between the 501y.v1 and the historical variants in nasopharyngeal samples from newly diagnosed covid-19 patients
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080495/
https://www.ncbi.nlm.nih.gov/pubmed/33932451
http://dx.doi.org/10.1016/j.jinf.2021.04.023
work_keys_str_mv AT teyssouelisa the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT souliecathia the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT visseauxbenoit the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT lambertniclotsidonie the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT ferrevalentine the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT marotstephane the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT jaryaude the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT sayonsophie the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT zafilazakaren the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT leducqvalentin the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT schnurigeraurelie the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT abdibasma the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT wirdenmarc the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT houhoufidouhnadhira the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT charpentiercharlotte the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT morandjoubertlaurence the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT burrelsonia the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT descampsdiane the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT calvezvincent the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT marcelinannegenevieve the501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT teyssouelisa 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT souliecathia 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT visseauxbenoit 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT lambertniclotsidonie 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT ferrevalentine 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT marotstephane 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT jaryaude 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT sayonsophie 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT zafilazakaren 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT leducqvalentin 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT schnurigeraurelie 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT abdibasma 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT wirdenmarc 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT houhoufidouhnadhira 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT charpentiercharlotte 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT morandjoubertlaurence 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT burrelsonia 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT descampsdiane 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT calvezvincent 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients
AT marcelinannegenevieve 501yv2sarscov2varianthasanintermediateviralloadbetweenthe501yv1andthehistoricalvariantsinnasopharyngealsamplesfromnewlydiagnosedcovid19patients